%A Imahashi,Mayumi %A Nakashima,Masaaki %A Iwatani,Yasumasa %D 2012 %J Frontiers in Microbiology %C %F %G English %K antiviral,APOBEC3,APOBEC3G,Cytidine Deaminase,HIV,Retrovirus,Reverse Transcription,Vif %Q %R 10.3389/fmicb.2012.00250 %W %L %M %P %7 %8 2012-July-09 %9 Mini Review %+ Dr Yasumasa Iwatani,National Hospital Organization Nagoya Medical Center,Clinical Research Center, Department of Microbiology and Immunology,4-1-1 San-no-Maru,Naka-ku,Nagoya,460-0001,Aichi,Japan,iwatani.yasumasa.cp@mail.hosp.go.jp %+ Dr Yasumasa Iwatani,Nagoya University,Graduate School of Medicine,Nagoya,Japan,iwatani.yasumasa.cp@mail.hosp.go.jp %# %! Molecular mechanism of APOBEC3 antiviral activity %* %< %T Antiviral Mechanism and Biochemical Basis of the Human APOBEC3 Family %U https://www.frontiersin.org/articles/10.3389/fmicb.2012.00250 %V 3 %0 JOURNAL ARTICLE %@ 1664-302X %X The human APOBEC3 (A3) family (A, B, C, DE, F, G, and H) comprises host defense factors that potently inhibit the replication of diverse retroviruses, retrotransposons, and the other viral pathogens. HIV-1 has a counterstrategy that includes expressing the Vif protein to abrogate A3 antiviral function. Without Vif, A3 proteins, particularly APOBEC3G (A3G) and APOBEC3F (A3F), inhibit HIV-1 replication by blocking reverse transcription and/or integration and hypermutating nascent viral cDNA. The molecular mechanisms of this antiviral activity have been primarily attributed to two biochemical characteristics common to A3 proteins: catalyzing cytidine deamination in single-stranded DNA (ssDNA) and a nucleic acid-binding capability that is specific to ssDNA or ssRNA. Recent advances suggest that unique property of A3G dimer/oligomer formations, is also important for the modification of antiviral activity. In this review article we summarize how A3 proteins, particularly A3G, inhibit viral replication based on the biochemical and structural characteristics of the A3G protein.